Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever [NA]

View source ↗

Summary

This clinical trial update describes an intravenous ribavirin protocol being studied for treatment of viral hemorrhagic fever, and the study is currently enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Viral Hemorrhagic Fever | NA | Status: ENROLLING_BY_INVITATION